Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Pharma
FDA signs off on AZ, Daiichi's Datroway for EGFR-mutated NSCLC
AZ and Daiichi have earned their second FDA approval for Datroway, scoring a nod for the drug to treat EGFR-mutated non-small cell lung cancer.
Kevin Dunleavy
Jun 24, 2025 8:10am
BMJ finds more irregularities in trial data for AZ's Brilinta
Jun 23, 2025 11:33am
AstraZeneca-CSPC, FDA, NMPA—Fierce Pharma Asia
Jun 20, 2025 11:28am
AZ touts Ultomiris results in post-transplant complication trial
Jun 16, 2025 10:32am
The 10 highest-paid Big Pharma CEOs of 2024
Jun 16, 2025 3:00am
Syntimmune shareholders win again over AZ, this time for $181M
Jun 12, 2025 11:40am
